The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Khandros Igor Y since 2005.
This trader's CIK number is 1256946.
At the time of last reporting, Khandros Igor Y was the Director of Bruker Cellular Analysis, Inc.. (stock ticker symbol CELL).
Also see all insider trading activities at Bruker Cellular Analysis, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2008 | FORM | 0 | $0 | 0 | $0 | 25,500 | $0 |
2007 | FORM | 0 | $0 | 111,400 | $4,993,845 | 0 | $0 |
2006 | FORM | 0 | $0 | 800,000 | $28,619,542 | 8,500 | $0 |
2005 | FORM | 0 | $0 | 120,000 | $3,216,150 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | CELL | 0 | $0 | 0 | $0 | 70,000 | $0 |
2021 | CELL | 0 | $0 | 300,000 | $10,970,547 | 0 | $0 |
2020 | CELL | 0 | $0 | 1,209,388 | $99,847,072 | 0 | $0 |
2. Bruker Cellular Analysis, Inc. (CELL)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2008-04-03 | FORM | Option Ex | 8,500 | .00 | 0 |
2008-04-03 | FORM | Option Ex | 8,500 | .00 | 0 |
2008-04-03 | FORM | Option Ex | 8,500 | .00 | 0 |
2007-10-16 | FORM | Sale | 10,000 | 43.00 | 430,000 |
2007-09-17 | FORM | Sale | 25,050 | 45.45 | 1,138,472 |
2007-09-17 | FORM | Sale | 4,950 | 46.13 | 228,353 |
2007-09-04 | FORM | Sale | 40,000 | 46.00 | 1,840,000 |
2007-08-17 | FORM | Sale | 10,000 | 43.68 | 436,820 |
2007-08-08 | FORM | Sale | 10,000 | 43.00 | 430,000 |
2007-06-18 | FORM | Sale | 1,400 | 43.00 | 60,200 |
2007-06-15 | FORM | Sale | 10,000 | 43.00 | 430,000 |
2006-08-30 | FORM | Sale | 20,000 | 49.00 | 980,000 |
2006-04-17 | FORM | Sale | 40,000 | 40.01 | 1,600,400 |
2006-04-03 | FORM | Option Ex | 8,500 | .00 | 0 |
2006-03-20 | FORM | Sale | 30,000 | 35.59 | 1,067,700 |
2006-03-16 | FORM | Sale | 50,000 | 37.30 | 1,864,999 |
2006-03-17 | FORM | Sale | 50,000 | 35.22 | 1,761,000 |
2006-03-15 | FORM | Sale | 50,000 | 37.65 | 1,882,350 |
2006-02-21 | FORM | Sale | 30,000 | 38.42 | 1,152,690 |
2006-02-17 | FORM | Sale | 50,000 | 38.86 | 1,943,100 |
2006-02-16 | FORM | Sale | 50,000 | 37.52 | 1,875,750 |
2006-02-15 | FORM | Sale | 50,000 | 37.93 | 1,896,350 |
2006-02-06 | FORM | Sale | 28,286 | 35.50 | 1,004,153 |
2006-02-03 | FORM | Sale | 75,000 | 35.71 | 2,678,100 |
2006-02-02 | FORM | Sale | 75,000 | 37.58 | 2,818,500 |
2006-02-01 | FORM | Sale | 18,343 | 30.53 | 560,011 |
2006-01-30 | FORM | Sale | 44,923 | 30.52 | 1,371,049 |
2006-01-27 | FORM | Sale | 75,000 | 30.50 | 2,287,500 |
2006-01-19 | FORM | Sale | 48,448 | 30.52 | 1,478,390 |
2006-01-17 | FORM | Sale | 15,000 | 26.50 | 397,500 |
2005-12-15 | FORM | Sale | 15,000 | 26.50 | 397,500 |
2005-11-18 | FORM | Sale | 15,000 | 26.50 | 397,500 |
2005-10-20 | FORM | Sale | 15,000 | 26.52 | 397,800 |
2005-09-15 | FORM | Sale | 15,000 | 27.08 | 406,200 |
2005-08-15 | FORM | Sale | 15,000 | 26.50 | 397,500 |
2005-07-15 | FORM | Sale | 15,000 | 27.55 | 413,250 |
2005-06-15 | FORM | Sale | 15,000 | 27.26 | 408,900 |
2005-05-24 | FORM | Sale | 15,000 | 26.50 | 397,500 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-10-02 | CELL | Option Ex | 70,000 | .00 | 0 |
2021-09-07 | BLI | Sale | 37,500 | 36.85 | 1,381,875 |
2021-09-09 | BLI | Sale | 37,500 | 36.37 | 1,363,762 |
2021-09-02 | BLI | Sale | 37,500 | 36.48 | 1,367,925 |
2021-08-31 | BLI | Sale | 37,500 | 35.91 | 1,346,512 |
2021-08-26 | BLI | Sale | 37,500 | 35.28 | 1,323,074 |
2021-08-24 | BLI | Sale | 37,500 | 35.01 | 1,312,762 |
2021-08-19 | BLI | Sale | 37,500 | 35.78 | 1,341,750 |
2021-08-12 | BLI | Sale | 37,500 | 40.88 | 1,532,887 |
2020-12-10 | BLI | Sale | 159,692 | 82.56 | 13,184,171 |
2020-11-23 | BLI | Sale | 1,049,696 | 82.56 | 86,662,901 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Khandros Igor Y (Director of Bruker Cellular Analysis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.